-
1
-
-
0032850439
-
Biochemical consequences of mutations causing the GM2 gangliosidoses
-
DOI 10.1016/S0925-4439(99)00074-5, PII S0925443999000745
-
Mahuran, DJ (1999). Biochemical consequences of mutations causing the GM2 gangliosidoses. Biochim Biophys Acta 1455: 105-138. (Pubitemid 29435983)
-
(1999)
Biochimica et Biophysica Acta - Molecular Basis of Disease
, vol.1455
, Issue.2-3
, pp. 105-138
-
-
Mahuran, D.J.1
-
2
-
-
0002623304
-
The GM2 gangliosidosis
-
In: Scriver, CR, Beaudet, AL, Sly, WS, Valle, D (eds) McGraw-Hill: New York.
-
Gravel, A, Kaback, M, Proia, RL, Sandhoff, K and Suzuki K (2001). The GM2 gangliosidosis. In: Scriver, CR, Beaudet, AL, Sly, WS, Valle, D (eds). The Metabolic and Molecular Bases of Inherited Diseases, 8th edn., vol. III. McGraw-Hill: New York. pp. 3827-3877.
-
(2001)
The Metabolic and Molecular Bases of Inherited Diseases, 8th Edn.
, vol.3
, pp. 3827-3877
-
-
Gravel, A.1
Kaback, M.2
Proia, R.L.3
Sandhoff, K.4
Suzuki, K.5
-
3
-
-
0035168688
-
Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation
-
DOI 10.1182/blood.V97.1.327
-
Jeyakumar, M, Norfus, F, Tifft, CJ, Cortina-Borja, M, Butters, TD, Proia, RL et al. (2001). Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation. Blood 97: 327-329. (Pubitemid 32061278)
-
(2001)
Blood
, vol.97
, Issue.1
, pp. 327-329
-
-
Jeyakumar, M.1
Norflus, F.2
Tiff, C.J.3
Cortina-Borja, M.4
Butters, T.D.5
Proia, R.L.6
Perry, V.H.7
Dwek, R.A.8
Platt, F.M.9
-
4
-
-
67651242502
-
Miglustat in late-onset Tay-Sachs disease: A 12-month, randomized, controlled clinical study with 24 months of extended treatment
-
Shapiro, BE, Pastores, GM, Gianutsos, J, Luzy, C and Kolodny, EH (2009). Miglustat in late-onset Tay-Sachs disease: a 12-month, randomized, controlled clinical study with 24 months of extended treatment. Genet Med 11: 425-433.
-
(2009)
Genet Med
, vol.11
, pp. 425-433
-
-
Shapiro, B.E.1
Pastores, G.M.2
Gianutsos, J.3
Luzy, C.4
Kolodny, E.H.5
-
5
-
-
33745925879
-
Effective gene therapy in an authentic model of Tay-Sachs-related diseases
-
DOI 10.1073/pnas.0603765103
-
Cachón-González, MB, Wang, SZ, Lynch, A, Ziegler, R, Cheng, SH and Cox, TM (2006). Effective gene therapy in an authentic model of Tay-Sachs-related diseases. Proc Natl Acad Sci USA 103: 10373-10378. (Pubitemid 44051174)
-
(2006)
Proceedings of the National Academy of Sciences of the United States of America
, vol.103
, Issue.27
, pp. 10373-10378
-
-
Cachon-Gonzalez, M.B.1
Wang, S.Z.2
Lynch, A.3
Ziegler, R.4
Cheng, S.H.5
Cox, T.M.6
-
6
-
-
34147160607
-
Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease
-
DOI 10.1038/nm1548, PII NM1548
-
Lee, J P, Jeyakumar, M, Gonzalez, R, Takahashi, H, Lee, PJ, Baek, RC et al. (2007). Stem cells act through multiple mechanisms to beneft mice with neurodegenerative metabolic disease. Nat Med 13: 439-447. (Pubitemid 46559825)
-
(2007)
Nature Medicine
, vol.13
, Issue.4
, pp. 439-447
-
-
Lee, J.-P.1
Jeyakumar, M.2
Gonzalez, R.3
Takahashi, H.4
Lee, P.-J.5
Baek, R.C.6
Clark, D.7
Rose, H.8
Fu, G.9
Clarke, J.10
McKercher, S.11
Meerloo, J.12
Muller, F.-J.13
Park, K.I.14
Butters, T.D.15
Dwek, R.A.16
Schwartz, P.17
Tong, G.18
Wenger, D.19
Lipton, S.A.20
Seyfried, T.N.21
Platt, F.M.22
Snyder, E.Y.23
more..
-
7
-
-
0025869216
-
Replacement therapy for inherited enzyme defciency-macrophage-targeted glucocerebrosidase for Gaucher's disease
-
Barton, NW, Brady, RO, Dambrosia, JM, Di Bisceglie, AM, Doppelt, SH, Hill, SC et al. (1991). Replacement therapy for inherited enzyme defciency-macrophage-targeted glucocerebrosidase for Gaucher's disease. N Engl J Med 324: 1464-1470.
-
(1991)
N Engl J Med
, vol.324
, pp. 1464-1470
-
-
Barton, N.W.1
Brady, R.O.2
Dambrosia, J.M.3
Di Bisceglie, A.M.4
Doppelt, S.H.5
Hill, S.C.6
-
8
-
-
62149099925
-
Dose-response relationships for enzyme replacement therapy with imiglucerase/alglucerase in patients with Gaucher disease type 1
-
Grabowski, GA, Kacena, K, Cole, JA, Hollak, CE, Zhang, L, Yee, J et al. (2009). Dose-response relationships for enzyme replacement therapy with imiglucerase/alglucerase in patients with Gaucher disease type 1. Genet Med 11: 92-100.
-
(2009)
Genet Med
, vol.11
, pp. 92-100
-
-
Grabowski, G.A.1
Kacena, K.2
Cole, J.A.3
Hollak, C.E.4
Zhang, L.5
Yee, J.6
-
9
-
-
0035811624
-
Safety and efficacy of recombinant human α-galactosidase a replacement therapy in Fabry's disease
-
DOI 10.1056/NEJM200107053450102
-
Eng, CM, Guffon, N, Wilcox, WR, Germain, DP, Lee, P, Waldek, S et al. (2001). Safety and effcacy of recombinant human alpha-galactosidase A-replacement therapy in Fabry's disease. N Engl J Med 345: 9-16. (Pubitemid 32634266)
-
(2001)
New England Journal of Medicine
, vol.345
, Issue.1
, pp. 9-16
-
-
Eng, C.M.1
Guffon, N.2
Wilcox, W.R.3
Germain, D.P.4
Lee, P.5
Waldek, S.6
Caplan, L.7
Linthorst, G.E.8
Desnick, R.J.9
-
10
-
-
0035746540
-
Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: Results of a phase I/II clinical trial
-
Amalftano, A, Bengur, AR, Morse, RP, Majure, JM, Case, LE, Veerling, DL et al. (2001). Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I/II clinical trial. Genet Med 3: 132-138.
-
(2001)
Genet Med
, vol.3
, pp. 132-138
-
-
Amalftano, A.1
Bengur, A.R.2
Morse, R.P.3
Majure, J.M.4
Case, L.E.5
Veerling, D.L.6
-
11
-
-
33846033132
-
Recombinant human acid α-glucosidase: Major clinical benefits in infantile-onset Pompe disease
-
DOI 10.1212/01.wnl.0000251268.41188.04, PII 0000611420070109000007
-
Kishnani, PS, Corzo, D, Nicolino, M, Byrne, B, Mandel, H, Hwu, WL et al. (2007). Recombinant human acid [alpha]-glucosidase: major clinical benefts in infantile-onset Pompe disease. Neurology 68: 99-109. (Pubitemid 46071892)
-
(2007)
Neurology
, vol.68
, Issue.2
, pp. 99-109
-
-
Kishnani, P.S.1
Corzo, D.2
Nicolino, M.3
Byrne, B.4
Mandel, H.5
Hwu, W.L.6
Leslie, N.7
Levine, J.8
Spencer, C.9
McDonald, M.10
Li, J.11
Dumontier, J.12
Halberthal, M.13
Chien, Y.H.14
Hopkin, R.15
Vijayaraghavan, S.16
Gruskin, D.17
Bartholomew, D.18
Van Der Ploeg, A.19
Clancy, J.P.20
Parini, R.21
Morin, G.22
Beck, M.23
De La Gastine, G.S.24
Jokic, M.25
Thurberg, B.26
Richards, S.27
Bali, D.28
Davison, M.29
Worden, M.A.30
Chen, Y.T.31
Wraith, J.E.32
more..
-
12
-
-
59449083175
-
Long-term effcacy and safety of laronidase in the treatment of mucopolysaccharidosis i
-
Clarke, LA, Wraith, JE, Beck, M, Kolodny, EH, Pastores, GM, Muenzer, J et al. (2009). Long-term effcacy and safety of laronidase in the treatment of mucopolysaccharidosis I. Pediatrics 123: 229-240.
-
(2009)
Pediatrics
, vol.123
, pp. 229-240
-
-
Clarke, L.A.1
Wraith, J.E.2
Beck, M.3
Kolodny, E.H.4
Pastores, G.M.5
Muenzer, J.6
-
13
-
-
39149118050
-
Mucopolysaccharidosis type II (Hunter syndrome): A clinical review and recommendations for treatment in the era of enzyme replacement therapy
-
Wraith, JE, Scarpa, M, Beck, M, Bodamer, OA, De Meirleir, L, Guffon, N et al. (2008). Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy. Eur J Pediatr 167: 267-277.
-
(2008)
Eur J Pediatr
, vol.167
, pp. 267-277
-
-
Wraith, J.E.1
Scarpa, M.2
Beck, M.3
Bodamer, O.A.4
De Meirleir, L.5
Guffon, N.6
-
14
-
-
41149092265
-
Intraventricular enzyme replacement improves disease phenotypes in a mouse model of late infantile neuronal ceroid lipofuscinosis
-
DOI 10.1038/mt.2008.9, PII MT20089
-
Chang, M, Cooper, JD, Sleat, DE, Cheng, SH, Dodge, JC, Passini, MA et al. (2008). Intraventricular enzyme replacement improves disease phenotypes in a mouse model of late infantile neuronal ceroid lipofuscinosis. Mol Ther 16: 649-656. (Pubitemid 351426165)
-
(2008)
Molecular Therapy
, vol.16
, Issue.4
, pp. 649-656
-
-
Chang, M.1
Cooper, J.D.2
Sleat, D.E.3
Cheng, S.H.4
Dodge, J.C.5
Passini, M.A.6
Lobel, P.7
Davidson, B.L.8
-
15
-
-
58149500258
-
Intracerebroventricular infusion of acid sphingomyelinase corrects CNS manifestations in a mouse model of Niemann-Pick A disease
-
Dodge, JC, Clarke, J, Treleaven, CM, Taksir, TV, Griffths, DA, Yang, W et al. (2009). Intracerebroventricular infusion of acid sphingomyelinase corrects CNS manifestations in a mouse model of Niemann-Pick A disease. Exp Neurol 215: 349-357.
-
(2009)
Exp Neurol
, vol.215
, pp. 349-357
-
-
Dodge, J.C.1
Clarke, J.2
Treleaven, C.M.3
Taksir, T.V.4
Griffths, D.A.5
Yang, W.6
-
16
-
-
4944239910
-
Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I
-
DOI 10.1016/j.ymgme.2004.07.003, PII S1096719204001763, ASHG 2004 Meeting Toronto
-
Kakkis, E, McEntee, M, Vogler, C, Le, S, Levy, B, Belichenko, P et al. (2004). Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I. Mol Genet Metab 83: 163-174. (Pubitemid 39328075)
-
(2004)
Molecular Genetics and Metabolism
, vol.83
, Issue.1-2
, pp. 163-174
-
-
Kakkis, E.1
McEntee, M.2
Vogler, C.3
Le, S.4
Levy, B.5
Belichenko, P.6
Mobley, W.7
Dickson, P.8
Hanson, S.9
Passage, M.10
-
17
-
-
49449090469
-
Neutralizing antibodies to therapeutic enzymes: Considerations for testing, prevention and treatment
-
Wang, J, Lozier, J, Johnson, G, Kirshner, S, Verthelyi, D, Pariser, A et al. (2008). Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment. Nat Biotechnol 26: 901-908.
-
(2008)
Nat Biotechnol
, vol.26
, pp. 901-908
-
-
Wang, J.1
Lozier, J.2
Johnson, G.3
Kirshner, S.4
Verthelyi, D.5
Pariser, A.6
-
18
-
-
0035826632
-
Identification of the 6-sulfate binding site unique to α-subunit-containing isozymes of human β-hexosaminidase
-
DOI 10.1021/bi0029200
-
Sharma, R, Deng, H, Leung, A and Mahuran, D (2001). Identifcation of the 6-sulfate binding site unique to alpha-subunit-containing isozymes of human beta-hexosaminidase. Biochemistry 40: 5440-5446. (Pubitemid 32458245)
-
(2001)
Biochemistry
, vol.40
, Issue.18
, pp. 5440-5446
-
-
Sharma, R.1
Deng, H.2
Leung, A.3
Mahuran, D.4
-
19
-
-
0037454663
-
A single site in human β-hexosaminidase A binds both 6-sulfate-groups on hexosamines and the sialic acid moiety of GM2 ganglioside
-
DOI 10.1016/S0925-4439(02)00221-1
-
Sharma, R, Bukovac, S, Callahan, J and Mahuran, D (2003). A single site in human beta-hexosaminidase A binds both 6-sulfate-groups on hexosamines and the sialic acid moiety of GM2 ganglioside. Biochim Biophys Acta 1637: 113-118. (Pubitemid 36071604)
-
(2003)
Biochimica et Biophysica Acta - Molecular Basis of Disease
, vol.1637
, Issue.1
, pp. 113-118
-
-
Sharma, R.1
Bukovac, S.2
Callahan, J.3
Mahuran, D.4
-
20
-
-
5444246274
-
An α-subunit loop structure is required for GM2 activator protein binding by β-hexosaminidase A
-
DOI 10.1016/j.bbrc.2004.09.159, PII S0006291X04022193
-
Zarghooni, M, Bukovac, S, Tropak, M, Callahan, J and Mahuran, D (2004). An alpha-subunit loop structure is required for GM2 activator protein binding by beta-hexosaminidase A. Biochem Biophys Res Commun 324: 1048-1052. (Pubitemid 39361614)
-
(2004)
Biochemical and Biophysical Research Communications
, vol.324
, Issue.3
, pp. 1048-1052
-
-
Zarghooni, M.1
Bukovac, S.2
Tropak, M.3
Callahan, J.4
Mahuran, D.5
-
21
-
-
0026767475
-
Analysis of the glycosylation and phosphorylation of the alpha-subunit of the lysosomal enzyme, beta-hexosaminidase A, by site-directed mutagenesis
-
Weitz, G and Proia, RL (1992). Analysis of the glycosylation and phosphorylation of the alpha-subunit of the lysosomal enzyme, beta-hexosaminidase A, by site-directed mutagenesis. J Biol Chem 267: 10039-10044.
-
(1992)
J Biol Chem
, vol.267
, pp. 10039-10044
-
-
Weitz, G.1
Proia, R.L.2
-
22
-
-
68749097166
-
Production of human beta-hexosaminidase A with highly phosphorylated N-glycans by the overexpression of the Ogataea minuta MNN4 gene
-
Akeboshi, H, Kasahara, Y, Tsuji, D, Itoh, K, Sakuraba, H, Chiba, Y et al. (2009). Production of human beta-hexosaminidase A with highly phosphorylated N-glycans by the overexpression of the Ogataea minuta MNN4 gene. Glycobiology 19: 1002-1009.
-
(2009)
Glycobiology
, vol.19
, pp. 1002-1009
-
-
Akeboshi, H.1
Kasahara, Y.2
Tsuji, D.3
Itoh, K.4
Sakuraba, H.5
Chiba, Y.6
-
23
-
-
4644316602
-
Enzyme therapy for Fabry disease: Neutralizing antibodies toward agalsidase alpha and beta
-
DOI 10.1111/j.1523-1755.2004.00924.x
-
Linthorst, GE, Hollak, CE, Donker-Koopman, WE, Strijland, A and Aerts, JM (2004). Enzyme therapy for Fabry disease: neutralizing antibodies toward agalsidase alpha and beta. Kidney Int 66: 1589-1595. (Pubitemid 39298394)
-
(2004)
Kidney International
, vol.66
, Issue.4
, pp. 1589-1595
-
-
Linthorst, G.E.1
Hollak, C.E.M.2
Donker-Koopman, W.E.3
Strijland, A.4
Aerts, J.M.F.G.5
-
24
-
-
48749103550
-
Immune tolerance improves the effcacy of enzyme replacement therapy in canine mucopolysaccharidosis i
-
Dickson, P, Peinovich, M, McEntee, M, Lester, T, Le, S, Krieger, A et al. (2008). Immune tolerance improves the effcacy of enzyme replacement therapy in canine mucopolysaccharidosis I. J Clin Invest 118: 2868-2876.
-
(2008)
J Clin Invest
, vol.118
, pp. 2868-2876
-
-
Dickson, P.1
Peinovich, M.2
McEntee, M.3
Lester, T.4
Le, S.5
Krieger, A.6
-
25
-
-
0028304962
-
Satisfying hydrogen bonding potential in proteins
-
DOI 10.1006/jmbi.1994.1334
-
McDonald, IK and Thornton, JM (1994). Satisfying hydrogen bonding potential in proteins. J Mol Biol 238: 777-793. (Pubitemid 24168633)
-
(1994)
Journal of Molecular Biology
, vol.238
, Issue.5
, pp. 777-793
-
-
McDonald, I.K.1
Thornton, J.M.2
-
26
-
-
0015222647
-
The interpretation of protein structures: Estimation of static accessibility
-
Lee, B and Richards, FM (1971). The interpretation of protein structures: estimation of static accessibility. J Mol Biol 55: 379-400.
-
(1971)
J Mol Biol
, vol.55
, pp. 379-400
-
-
Lee, B.1
Richards, F.M.2
-
27
-
-
0344837327
-
Crystal Structure of Human β-Hexosaminidase B: Understanding the Molecular Basis of Sandhoff and Tay-Sachs Disease
-
DOI 10.1016/S0022-2836(03)00216-X
-
Mark, BL, Mahuran, DJ, Cherney, MM, Zhao, D, Knapp, S and James, MN (2003). Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease. J Mol Biol 327: 1093-1109. (Pubitemid 36363715)
-
(2003)
Journal of Molecular Biology
, vol.327
, Issue.5
, pp. 1093-1109
-
-
Mark, B.L.1
Mahuran, D.J.2
Cherney, M.M.3
Zhao, D.4
Knapp, S.5
James, M.N.G.6
-
28
-
-
0025183708
-
Basic local alignment search tool
-
Altschul, SF, Gish, W, Miller, W, Myers, EW and Lipman, DJ (1990). Basic local alignment search tool. J Mol Biol 215: 403-410.
-
(1990)
J Mol Biol
, vol.215
, pp. 403-410
-
-
Altschul, S.F.1
Gish, W.2
Miller, W.3
Myers, E.W.4
Lipman, D.J.5
-
29
-
-
84986432905
-
Accurate modeling of the intramolecular electrostatic energy of proteins
-
Dudek, MJ and Ponder, JW (1995). Accurate modeling of the intramolecular electrostatic energy of proteins. J Comput Chem 16: 791-816.
-
(1995)
J Comput Chem
, vol.16
, pp. 791-816
-
-
Dudek, M.J.1
Ponder, J.W.2
-
30
-
-
84962376142
-
Calculation of the reaction field due to off-center point multipoles
-
Kong, MJ and Ponder, JW (1997). Reaction feld methods for off-center multipoles. J Chem Phys 107: 481-492. (Pubitemid 127564373)
-
(1997)
Journal of Chemical Physics
, vol.107
, Issue.2
, pp. 481-492
-
-
Kong, Y.1
Ponder, J.W.2
-
31
-
-
0038424321
-
Analysis and application of potential energy smoothing and search methods for global optimization
-
Pappu, RV, Hart, RK and Ponder, JW (1998). Analysis and application of potential energy smoothing and search methods for global optimization. J Phys Chem B102: 9725-9742. (Pubitemid 128591379)
-
(1998)
Journal of Physical Chemistry B
, vol.102
, Issue.48
, pp. 9725-9742
-
-
Pappu, R.V.1
Hart, R.K.2
Ponder, J.W.3
-
32
-
-
0037899660
-
Polarizable atomic multipole water model for molecular mechanics simulation
-
Ren, P and Ponder, JW (2003). Polarizable atomic multipole water model for molecular mechanics simulation. J Phys Chem B107: 5933-5947.
-
(2003)
J Phys Chem B
, vol.107
, pp. 5933-5947
-
-
Ren, P.1
Ponder, J.W.2
-
33
-
-
33746691326
-
Inefficiency in GM2 ganglioside elimination by human lysosomal β-hexosaminidase β-subunit gene transfer to fibroblastic cell line derived from Sandhoff disease model mice
-
DOI 10.1248/bpb.29.1564
-
Itakura, T, Kuroki, A, Ishibashi, Y, Tsuji, D, Kawashita, E, Higashine, Y et al. (2006). Ineffciency in GM2 ganglioside elimination by human lysosomal beta-hexosaminidase beta-subunit gene transfer to fbroblastic cell line derived from Sandhoff disease model mice. Biol Pharm Bull 29: 1564-1569. (Pubitemid 44166352)
-
(2006)
Biological and Pharmaceutical Bulletin
, vol.29
, Issue.8
, pp. 1564-1569
-
-
Itakura, T.1
Kuroki, A.2
Ishibashi, Y.3
Tsuji, D.4
Kawashita, E.5
Higashine, Y.6
Sakuraba, H.7
Yamanaka, S.8
Itoh, K.9
-
34
-
-
33846937578
-
Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies
-
DOI 10.1016/j.cca.2006.10.010, PII S000989810600698X
-
Tsuji, D, Higashine, Y, Matsuoka, K, Sakuraba, H and Itoh, K (2007). Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies. Clin Chim Acta 378: 38-41. (Pubitemid 46241058)
-
(2007)
Clinica Chimica Acta
, vol.378
, Issue.1-2
, pp. 38-41
-
-
Tsuji, D.1
Higashine, Y.2
Matsuoka, K.3
Sakuraba, H.4
Itoh, K.5
-
35
-
-
0023161242
-
Enzymatic diagnosis of sphingolipidosis
-
In: Ginsbury V (ed) Academic Press: New York.
-
Suzuki, K (1987). Enzymatic diagnosis of sphingolipidosis. In: Ginsbury V (ed). Methods in Enzymology, vol. 138. Academic Press: New York. pp. 727-763.
-
(1987)
Methods in Enzymology
, vol.138
, pp. 727-763
-
-
Suzuki, K.1
|